We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

42 hedge funds and large institutions have $128M invested in Five Prime Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,800% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 1

1,827% more capital invested

Capital invested by funds: $6.62M → $128M (+$121M)

950% more funds holding

Funds holding: 4 → 42 (+38)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
42
Holders Change
+38
Holders Change %
+950%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$14.9M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$13.1M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.5M
4
WT
Wellcome Trust
United Kingdom
+$6.47M
5
Goldman Sachs
Goldman Sachs
New York
+$5.95M

Top Sellers

Rank Fund Capital Flow
1
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$621K
2
MCM
Mazama Capital Management
Oregon
-$40K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.23K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$333K +$246K +19,823 New
MWNA
27
Marshall Wace North America
New York
$314K +$232K +18,700 New
TCIM
28
TIAA CREF Investment Management
New York
$254K +$188K +15,150 New
BIM
29
BlackRock Investment Management
Delaware
$215K +$159K +12,786 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$191K +$142K +11,389 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$171K +$127K +10,200 New
BA
32
BlackRock Advisors
Delaware
$107K +$79.3K +6,385 New
TA
33
Teachers Advisors
New York
$93K +$69K +5,550 New
NFA
34
Nationwide Fund Advisors
Ohio
$71K +$52.2K +4,203 New
AIG
35
American International Group
New York
$62.6K +$46.3K +3,728 New
Citigroup
36
Citigroup
New York
$46K +$33.8K +2,719 New
SO
37
STRS Ohio
Ohio
$39K +$28.6K +2,300 New
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$17K +$12.4K +1,000 New
Morgan Stanley
39
Morgan Stanley
New York
$8K +$5.73K +461 New
U
40
UBS
Switzerland
$8K +$5.73K +461 New
Barclays
41
Barclays
United Kingdom
$1K +$1.13K +91 New
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 +$1.6K +129 New
MCM
43
Mazama Capital Management
Oregon
– -$40K -3,088 Closed
1
2

FPRX Hedge Fund Activity: Q4 2013 in Review

42 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2013, worth a combined $128M — up 1,827% from $6.62M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new FPRX positions and 1 closed out — a net gain of 38 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $14.9M. The largest seller was Austin W. Marxe & David M. Greenhouse, cutting an estimated $621K.

  • 42 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2013, up from 4 in Q3 2013.
  • Funds reported $128M of Five Prime Therapeutics, Inc. stock for Q4 2013, up 1,827% quarter-over-quarter.
  • 39 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2013 and 1 closed out, a net change of +38 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q4 2013 was HealthCor Management, an estimated $14.9M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q4 2013 was Austin W. Marxe & David M. Greenhouse, an estimated $621K sold.

Based on aggregated 13F filings for Q4 2013.